Cove Street Capital, LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 72 filers reported holding TRINITY BIOTECH PLC in Q4 2016. The put-call ratio across all filers is 55.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cove Street Capital, LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q1 2018$473,000
+0.9%
91,9000.0%0.05%
+2.0%
Q4 2017$469,000
-9.1%
91,9000.0%0.05%
-12.1%
Q3 2017$516,000
-57.0%
91,900
-54.0%
0.06%
-60.3%
Q2 2017$1,200,000
+0.7%
200,0000.0%0.15%
+15.9%
Q1 2017$1,192,000
-13.9%
200,0000.0%0.13%
-13.1%
Q4 2016$1,384,000200,0000.14%
Other shareholders
TRINITY BIOTECH PLC shareholders Q4 2016
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders